Translation of Recovering Quality of Life (ReQoL) to Hindi: addressing linguistic issues
Journal Title: Journal of Geriatric Care and Research - Year 2018, Vol 5, Issue 1
Abstract
The linguistic validation process of the Recovering Quality of Life (ReQoL) scale to Hindi, the national language of India, was undertaken by a team of mental health professionals at Post Graduate Institute of Medical Sciences, Rohtak, India. The standard process of translation and review was followed. The translated Hindi version of ReQoL was considered acceptable. The process of translation and the linguistic issues encountered during the process are discussed.
Authors and Affiliations
Sujata Sethi, Vikas Punia, Hitesh Khurana, Nilamadhab Kar
Keywords
Related Articles
- EP ID EP550393
- DOI -
- Views 56
- Downloads 0
Social impact of ageing in people with intellectual disabilities.
Introduction: People with intellectual disabilities have a longer life expectancy than ever before, which is resulting in an increase in population of the elderly in this group. There is scant information about ageing re...
Introducing the PHE National Prevention Concordat for Better Mental Health
Just over a month ago, Public Health England (PHE) released the Prevention Concordat for Better Mental Health. This “concordat” aims to help local authorities, Health and Wellbeing Boards, Clinical Commissioning Groups (...
English to Tamil translation and linguistic validation of Recovering Quality of Life scale (ReQoL)
The linguistic validation process of the Recovering Quality of Life (ReQoL) scale to the Indian language Tamil was undertaken by a team of mental health professionals at Schizophrenia Research Foundation, Chennai. The pr...
Cardio-metabolic syndrome – an intervention framework
Cardio-metabolic syndrome is a closely clustered group of dysfunctional metabolic parameters, predominantly characterised by a) impaired glucose tolerance or insulin resistance, b) central obesity or intra-abdominal adip...
Galantamine-memantine combination superior to donepezil-memantine combination in Alzheimer’s disease: critical dissection with an emphasis on kynurenic acid and mismatch negativity
Background: The donepezil-memantine combination is a US Food and Drug Administration (FDA)–approved medication to treat Alzheimer’s disease (AD). Galantamine is superior to donepezil because it is a positive allosteric m...